NCT02626312 2026-04-16
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
Clinical Trials
40 trialsNCT03186898 2026-04-03
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
NRG Oncology
Phase 3 Active not recruiting
NCT02439008 2026-03-13
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
Centre Oscar Lambret
Phase NA Terminated
NCT07179900 2025-12-11
Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma
Hebei Medical University Fourth Hospital
Phase 2 Not yet recruiting
NCT07274774 2025-12-10
SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
Phase 2 Recruiting
NCT06994299 2025-11-18
PRISM
Weill Medical College of Cornell University
Phase 2 Withdrawn
NCT04221893 2025-10-06
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
University of California, San Francisco
Phase NA Recruiting
NCT04857684 2025-10-01
SBRT + Atezolizumab + Bevacizumab in Resectable HCC
Massachusetts General Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT07186621 2025-09-22
Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3 Recruiting
NCT04791176 2025-08-14
Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Completed
NCT06841172 2025-08-01
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC
Shandong Cancer Hospital and Institute
Phase 3 Recruiting
NCT04745390 2025-03-11
SAVIOR
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Recruiting
NCT06870942 2025-03-11
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
Shanghai Zhongshan Hospital
Phase 2 Recruiting
NCT06261047 2024-10-03
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
Shandong Cancer Hospital and Institute
Recruiting
NCT03960008 2024-08-28
SBRTvsTACE
Lahey Clinic
Phase 3 Terminated
NCT04451603 2024-03-13
LiverMultiScan Analysis of MRI Scans in HCC
National Cancer Centre, Singapore
Completed
NCT02182687 2024-03-05
SBRTvsTACE
Lahey Clinic
Phase 2 Completed
NCT05010434 2023-09-21
Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT05225116 2023-02-08
Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
Beijing Tsinghua Chang Gung Hospital
Phase 1 Unknown
NCT02125396 2023-01-27
ARTC-HCC
Guangxi Medical University
Phase 3 Unknown
NCT03988998 2022-01-18
Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma
Guangxi Medical University
Phase 3 Unknown
NCT04653389 2022-01-11
Perioperative Therapy for Hepatocellular Carcinoma
Zhejiang University
Phase 2 Terminated
NCT02395523 2020-07-07
Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma
National Cancer Center, Korea
Phase NA Completed
NCT04104074 2020-07-07
Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital
Phase 1 Unknown
NCT02989870 2020-06-05
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Withdrawn
NCT04193696 2020-01-09
RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)
Guangxi Medical University
Phase 2 Unknown
NCT01643824 2018-08-23
Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma
National Cancer Center, Korea
Phase NA Completed
NCT01528878 2018-07-26
Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed
NCT03520257 2018-05-09
The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus
Guangxi Medical University
Phase 2 Unknown
NCT03416803 2018-02-05
A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT02580929 2015-10-22
Clinical Study of Effectiveness of Radiotherapy Before Surgery in High-risk Relapse Hepatocellular Cancer Patients
Peking Union Medical College
Phase NA Unknown
NCT01432314 2014-06-26
RTANDTACE
Asan Medical Center
Phase 2 Withdrawn
NCT01618253 2013-09-05
Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma
Medical College of Wisconsin
Phase 1 Withdrawn
NCT00002608 2013-07-10
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 2 Completed
NCT00469963 2012-09-03
Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT00030511 2012-07-16
Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT01328223 2011-04-04
Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma
China Medical University Hospital
Unknown
NCT01319942 2011-03-22
Combined Radiotherapy and Sorafenib in Patients With Hepatoma
China Medical University Hospital
Unknown
NCT00960167 2009-10-15
A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)
National Taiwan University Hospital
Phase 1 Unknown
NCT00154817 2005-11-22
A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)
National Taiwan University Hospital
Phase 2 Completed